Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet treatment in type 2 diabetes: comparison of aspirin, clopidogrel and prasugrel
2009-011907-22Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of aspirin, clopidogrel and prasugrel in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by University of Leeds. Primary endpoints: Platelet activation parameters and Clot structure and function parameters. Started Mar 2010; status: completed.
02
Drugs
aspirinclopidogrelprasugrel
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-011907-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011907-22.